Cargando…

Immunotherapy for acute leukemia

Detalles Bibliográficos
Autores principales:	Boyiadzis, Michael, Whiteside, Theresa L, Pavletic, Steven Z
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4505159/ https://www.ncbi.nlm.nih.gov/pubmed/26143183

Ejemplares similares

Circulating exosomes carrying an immunosuppressive cargo interfere with cellular immunotherapy in acute myeloid leukemia
por: Hong, Chang-Sook, et al.
Publicado: (2017)

Plasma Exosomes as Markers of Therapeutic Response in Patients with Acute Myeloid Leukemia
por: Hong, Chang-Sook, et al.
Publicado: (2014)

Isolation and Characterization of CD34+ Blast-Derived Exosomes in Acute Myeloid Leukemia
por: Hong, Chang Sook, et al.
Publicado: (2014)

Chondroitin Sulfate Proteoglycan-4 (CSPG4)-Specific Monoclonal Antibody 225.28 in Detection of Acute Myeloid Leukemia Blasts
por: Fenton, Moon, et al.
Publicado: (2015)

Circulating exosomes carrying an immunosuppressive cargo may interfere with adoptive cell therapies in leukemia
por: Boyiadzis, Michael, et al.
Publicado: (2015)

Biologically-active exosomes in plasma of AML patients inhibit innate immunity and promote leukemia progression
por: Boyiadzis, Michael, et al.
Publicado: (2015)

Response Commentary: Exosomes vs microvesicles in hematological malignancies
por: Whiteside, Theresa L., et al.
Publicado: (2017)

Increased small extracellular vesicle secretion after chemotherapy via upregulation of cholesterol metabolism in acute myeloid leukaemia
por: Hong, Chang-Sook, et al.
Publicado: (2020)

Chemotherapy Promotes Release of Exosomes Which Upregulate Cholesterol Synthesis and Chemoresistance in AML Blasts
por: Hong, Chang-Sook, et al.
Publicado: (2021)

The Important Role of Immunotherapies in Acute Myeloid Leukemia
por: Greiner, Jochen
Publicado: (2019)

The Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia
por: Boyiadzis, Michael M, et al.
Publicado: (2020)

Forty years of hematopoietic stem cell transplantation in Croatia: First-World options and First-World science
por: Pavletic, Steven Z.
Publicado: (2023)

Immunotherapy in hematologic malignancies: past, present, and future
por: Im, Annie, et al.
Publicado: (2017)

Isolation of biologically active and morphologically intact exosomes from plasma of patients with cancer
por: Hong, Chang-Sook, et al.
Publicado: (2016)

New Horizons in Immunology and Immunotherapy of Acute Leukemias and Related Disorders
por: Lanza, Francesco, et al.
Publicado: (2023)

Durable discontinuation of systemic therapy for chronic graft-versus-host disease: myth or reality?
por: Pavletic, Steven Z., et al.
Publicado: (2022)

AML treatment in older adults
por: Sehgal, Alison, et al.
Publicado: (2015)

Proteomic Analysis of Plasma-Derived Exosomes in Defining Their Role as Biomarkers of Disease Progression, Response to Therapy and Outcome
por: Whiteside, Theresa L.
Publicado: (2019)

The potential of microRNA carried by small extracellular vesicles in cancer plasma to serve as cancer biomarkers
por: Whiteside, Theresa L.
Publicado: (2023)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia
por: Boyiadzis, Michael, et al.
Publicado: (2016)

In memoriam: Soldano Ferrone, MD, PhD (1940–2023)
por: Whiteside, Theresa, et al.
Publicado: (2023)

Chronic graft-vs-host disease in 2016: a major challenge and an opportunity
por: Pulanić, Dražen, et al.
Publicado: (2016)

Disrupting autophagy in FLT3-mutant acute myeloid leukemia
por: Grant, Steven
Publicado: (2022)

Acute Leukemia in Children
por: Mejía-Aranguré, Juan Manuel, et al.
Publicado: (2015)

Acute Promyelocytic Leukemia
por: Thomas, Xavier, et al.
Publicado: (2020)

Emerging Immunotherapy for Acute Myeloid Leukemia
por: Tabata, Rikako, et al.
Publicado: (2021)

Immunologic Monitoring of Cellular Immune Responses in Cancer Vaccine Therapy
por: Whiteside, Theresa L., et al.
Publicado: (2011)

Recent developments in immunotherapy of acute myeloid leukemia
por: Lichtenegger, Felix S., et al.
Publicado: (2017)

The Role of T Cell Immunotherapy in Acute Myeloid Leukemia
por: Hao, Fang, et al.
Publicado: (2021)

Current status of immunotherapy in acute myeloid leukemia
por: Subklewe, Marion
Publicado: (2018)

Facts and Challenges in Immunotherapy for T-Cell Acute Lymphoblastic Leukemia
por: Bayón-Calderón, Fátima, et al.
Publicado: (2020)

Mitoxantrone and Etoposide for the Treatment of Acute Myeloid Leukemia Patients in First Relapse
por: Im, Annie, et al.
Publicado: (2016)

Fusion genes in acute myeloid leukemia: do acute myeloid leukemia diagnostics need to fuse with RNA-sequencing?
por: Thol, Felicitas
Publicado: (2022)

Tumour-derived exosomes or microvesicles: another mechanism of tumour escape from the host immune system?
por: Whiteside, T L
Publicado: (2005)

Epigenetic targeting to enhance acute myeloid leukemia-directed immunotherapy
por: Rausch, Johanna, et al.
Publicado: (2023)

Intensive Chemotherapy in Patients Aged 70 Years or Older Newly Diagnosed With Acute Myeloid Leukemia
por: Ross, Kelly, et al.
Publicado: (2015)

Immersion in the search for effective cancer immunotherapies
por: Rosenberg, Steven A.
Publicado: (2021)

Chronic myeloid leukemia versus acute myeloid leukemia in patients with retinoblastoma
por: Leahey, Ann-Marie, et al.
Publicado: (2021)

NOX2: a determinant of acute myeloid leukemia survival
por: Jones, Courtney L.
Publicado: (2022)

Mixed-phenotype acute leukemia (MPAL) and beyond
por: Kim, Hee-Je
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_h0ub639f1u6ae9ls63ns088ebj